COVID-19 mRNA vaccine triggering dermatomyositis: A case report
Loading...
Date
2022-12
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Scientific Scholar
Abstract
The battle against SARS-COV-2 is rising and the hope in the safety and effectiveness of immunization against this virus is growing up, even though serious and severe adverse events are scarcely observed. In this article, we report a case of mRNA vaccine induced an autoimmune dermatomyositis with features of severity that are managed by immunosuppressants medications and still in regular follow-up. Inflammatory dermatomyositis can be triggered after vaccination with COVID vaccine in the same mechanism that COVID-19 infection-induced myositis.
Description
Keywords
Dermatomyositis, mRNA vaccine, COVID-19, Heliotrope rash, Cyclophosphamide
Citation
Awadh NI, Gorial FI, Al-Laylaa RD, Ismail M.. COVID-19 mRNA vaccine triggering dermatomyositis: A case report. Indian Journal of Medical Sciences. 2022 Dec; 74(3): 145-147